Stem cells are transforming modern medicine by accelerating wound healing, repairing tissue, and enhancing skin aesthetics, according to Professor Dr. M. Al-Fareed Zafar, Principal of Ameer Uddin ...

Patients with severe dystrophic epidermolysis bullosa, or EB, have skin so fragile, the slightest touch can lead to ...

GRAPEVINE, TX, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- A comprehensive, multicenter retrospective study showed positive findings evaluating the safety and efficacy of using mechanical ...

As the first compound in a new drug class, pravibismane provides uniquely broad-spectrum biofilm eradication activity.” — Dr. Brett Baker, Founder and Chief Innovation Officer at Microbion GRAPEVINE, ...

Human wounds heal around three times slower than those sustained by other primates, which may be a result of our specific ...

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

A new exhibit at the Cleveland Botanical Garden uses art to explore the healing power of nature and pathways it can provide ...

A team of evolutionary scientists, dermatologists and wildlife specialists affiliated with several institutions in Japan, ...

Researchers have found that wounds heal three times more slowly in humans than in other primates and rodents, suggesting we ...

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...